Corneal confocal microscopy is helpful in VKC

Article

Corneal confocal microscopy is useful for studying in vivo pathologic corneal changes in vernal keratoconjunctivitis (VKC).

Corneal confocal microscopy is useful for studying in vivo pathologic corneal changes in vernal keratoconjunctivitis (VKC), claims a study in the journal Ophthalmology.

Dr Andrea Leonardi et al., Department of Neuroscience, Ophthalmology Unit, University of Padova, Padova, Italy, completed a prospective, comparative case study on 32 patients with VKC and 40 normal participants.

All patients underwent a full ophthalmic examination and central cornea images were gathered using a x40 non-contact lens and a Z-ring device. The main outcome measures were the superficial and basal epithelium, subbasal nerve plexus, anterior stroma, stromal nerves and endothelium of the central cornea.

It was discovered that the VKC patients had increased diameter, reflectivity and presence of nuclear activation of superficial epithelial cells. They also had a reduced basal membrane density, an increased presence of activated keratocytes and inflammatory cells in the anterior stroma.

The VKC patients also presented with lower density and number of fibres, lower number of beadings and a higher grade of tortuosity of fibres in the subbasal nerve plexus. In the stromal corneal nerves there was an increased thickness, deflections and tortuosity changes.

The study authors concluded that the changes in the epithelium and subbasal and stromal corneal nerves could be linked to tear dysfunction and non-specific hyperactivity.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.